Fulgent Genetics (FLGT) Total Debt (2020 - 2026)

Fulgent Genetics has disclosed Total Debt across 7 years of filings, most recently posting $2.0 million for Q2 2026.

• In Q2 2026, Total Debt fell 19.56% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $2.0 million (down 19.56% YoY), while the FY2025 annual figure was $2.4 million, down 16.21% from the prior year.
• Total Debt came in at $2.0 million for Q2 2026 at Fulgent Genetics, roughly flat from $2.0 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $26.7 million in Q1 2022 to a low of $2.0 million in Q1 2026.
• Average Total Debt over 5 years is $9.6 million, with a median of $2.9 million recorded in 2024.
• Year-over-year, Total Debt surged 77.34% in 2022 and sank 88.74% in 2024.
• Over 5 years, Total Debt stood at $24.0 million in 2022, then tumbled by 82.73% to $4.1 million in 2023, then decreased by 29.95% to $2.9 million in 2024, then slipped by 16.21% to $2.4 million in 2025, then dropped by 19.56% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $2.0 million in Q2 2026, $2.0 million in Q1 2026, and $2.4 million in Q4 2025.